Adenoviral Delivery of Osteoprotegerin Ameliorates Bone Resorption in a Mouse Ovariectomy Model of Osteoporosis-Reference-Cited by-同舟云学术

Adenoviral Delivery of Osteoprotegerin Ameliorates Bone Resorption in a Mouse Ovariectomy Model of Osteoporosis

Published:2001-02 Issue:2 Volume:3 Page:197-205
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Bolon Brad,Carter Christopher,Daris Mark,Morony Sean,Capparelli Casey,Hsieh Angela,Mao Mingfu,Kostenuik Paul,Dunstan Colin R.,Lacey David L.,Sheng Jackie Z.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference41 articles.

1. How many women have osteoporosis now?;Melton;J. Bone Miner. Res.,1995

2. Hormone replacement therapy;Compston;Clin. Rheumatol.,1997

3. An expanding landscape. Osteoporosis: Treatment options today;Meiner;Adv. Nurse Pract.,1999

4. Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption;Aubin;Women's Health,2000

5. Advances in bone biology: The osteoclast;Roodman;Endocr. Rev.,1996

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OPG gene-modified adipose-derived stem cells improve bone formation around implants in osteoporotic rat maxillae;Heliyon;2023-10

2. Scientific and Regulatory Policy Committee Points to Consider: Nonclinical Research and Development of In Vivo Gene Therapy Products, Emphasizing Adeno-Associated Virus Vectors;Toxicologic Pathology;2021-10-17

3. Targeting Drug Delivery in the Elderly: Are Nanoparticles an Option for Treating Osteoporosis?;International Journal of Molecular Sciences;2021-08-19

4. Osteoprotegerin (OPG) pathways in bone diseases and its application in therapeutic perspectives;Biointerface Research in Applied Chemistry;2020-02-03

5. Effects of IL-34 on the secretion of RANKL/OPG by fibroblast-like synoviocytes and peripheral blood mononuclear cells in rheumatoid arthritis;European Cytokine Network;2019-06